Homocysteine is associated with hippocampal and white matter atrophy in older subjects with mild hypertension

International Psychogeriatrics

Volumn 22, Issue 5, 2010, Pages 804-811

  Firbank, Michael J ^a   Narayan, Sunil K ^a   Saxby, Brian K ^a   Ford, Gary A ^a   O'Brien, John T ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

brain atrophy; dementia; hippocampus; homocysteine; MRI

Indexed keywords

CREATININE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

AGE; AGED; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; BORDERLINE HYPERTENSION; BRAIN ATROPHY; BRAIN DAMAGE; CORRELATION ANALYSIS; FEMALE; FOLIC ACID BLOOD LEVEL; GRAY MATTER; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; STATISTICAL SIGNIFICANCE; WHITE MATTER; ATROPHY; BLOOD; BRAIN; HYPERTENSION; MYELINATED NERVE; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATROPHY; BRAIN; FEMALE; HIPPOCAMPUS; HOMOCYSTEINE; HUMANS; HYPERTENSION; MAGNETIC RESONANCE IMAGING; MALE; NERVE FIBERS, MYELINATED;

EID: 77957356998     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610210000499     Document Type: Article

References (27)

1. Back, T., Hemmen, T. and Schüler, O. G. (2004). Lesion evolution in cerebral ischemia. Journal of Neurology, 251, 388-397.
2. Clarke, R., Smith, A. D., Jobst, K. A., Refsum, H., Sutton, L. and Ueland, P. M. (1998). Folate, Vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Archives of Neurology, 55, 1449-1455.
3. den Heijer, T. et al. (2003). Homocysteine and brain atrophy on MRI of non-demented elderly. Brain, 126, 170-175.
4. Fazekas, F. et al. (1993). Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology, 43, 1683-1689.
5. Firbank, M. J., Wiseman, R. M., Burton, E. J., Saxby, B. K., O'Brien, J. T. and Ford, G. A. (2007). Brain atrophy and white matter hyperintensity change in older adults and relationship to blood pressure. Journal of Neurology, 254, 713-721.
6. Firbank, M. J., Barber, R., Burton, E. J. and O'Brien, J. T. (2008). Validation of a fully automated hippocampal segmentation method on patients with dementia. Human Brain Mapping, 29, 1442-1449.
7. Hansson, L. et al. (1999). Study on Cognition and Prognosis in the Elderly (SCOPE). Blood Pressure, 8, 177-183.
8. Hogervorst, E., Huppert, F., Matthews, F. E. and Brayne, C. (2008). Thyroid function and cognitive decline in the MRC Cognitive Function and Ageing Study. Psychoneuroendocrinology, 33, 1013-1022.
9. Lonati, S. et al. (2004). Analytical performance and method comparison study of the total homocysteine fluorescence polarization immunoassay (FPIA) on the AxSYM analyzer. Clinical Chemistry and Laboratory Medicine, 42, 228-234.
10. Longstreth, W. T. et al. (2004). Plasma total homocysteine levels and cranial magnetic resonance imaging findings in elderly persons: the Cardiovascular Health Study. Archives of Neurology, 61, 67-72.
11. Narayan, S. K. et al. (submitted). Plasma homocysteine levels are associated with increased brain atrophy rates in older subjects with mild hypertension. Stroke.
12. Obeid, R. and Herrmann, W. (2006). Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Letters, 580, 2994-3005.
13. Ozmen, B., Ozmen, D., Parildar, Z., Mutaf, I., Turgan, N. and Bayindir, O. (2006). Impact of renal function or folate status on altered plasma homocysteine levels in hypothyroidism. Endocrine Journal, 53, 119-124.
14. Peper, J. S., Brouwer, R. M., Boomsma, D. I., Kahn, R. S. and Hulshoff Pol, H. E. (2007). Genetic influences on human brain structure: A review of brain imaging studies in twins. Human Brain Mapping, 28, 464-473.
15. Pernet, P., Lasnier, E. and Vaubourdolle, M. (2000). Evaluation of the AxSYM homocysteine assay and comparison with the IMx homocysteine assay. Clinical Chemistry, 46, 1440-1441.
16. Popp, J. et al. (2009). Homocysteine metabolism and cerebrospinal fluid markers for Alzheimer's disease. Journal of Alzheimer's Disease, 18, 819-828.
17. Rasmussen, K. and Møllerer, J. (2001). Methodologies of testing. In R. Carmel and D. W. Jacobsen (eds.), Homocysteine in Health and Disease. Cambridge: Cambridge University Press.
18. Ravaglia, G. et al. (2007). Blood inflammatory markers and risk of dementia: The conselice study of brain aging. Neurobiology of Aging, 28, 1810-1820. (Pubitemid 47539699)
19. Sachdev, P. S. (2005). Homocysteine and brain atrophy. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 29, 1152-1161.
20. Sachdev, P. et al. (2004). Homocysteine and the brain in midadult life - Evidence for an increased risk of leukoaraiosis in men. Archives of Neurology, 61, 1369-1376.
21. Saxby, B. K., Harrington, F., Wesnes, K., McKeith, I. G. and Ford, G. A. (2008). Candesartan and cognitive decline in older patients with hypertension: a substudy of the SCOPE trial. Neurology, 70, 1858-1866.
22. Seshadri, S. et al. (2002). Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. New England Journal of Medicine, 346, 476-483. (Pubitemid 34441738)
23. Seshadri, S. et al. (2008). Association of plasma total homocysteine levels with subclinical brain injury. Archives of Neurology, 65, 642-649.
24. Shuter, B., Yeh, I. B., Graham, S., Au, C. and Wang, S.-C. (2008). Reproducibility of brain tissue volumes in longitudinal studies: effects of changes in signal-to-noise ratio and scanner software. Neuroimage, 41, 371-379
25. Vermeer, S. E. et al. (2002). Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam scan study. Annals of Neurology, 51, 285-289.
26. Whalley, L. J. et al. (2003). Plasma vitamin C, cholesterol and homocysteine are associated with grey matter volume determined by MRI in non-demented old people. Neuroscience Letters, 341, 173-176.
27. Williams, J. H., Pereira, E. A. C., Budge, M. M. and Bradley, K. M. (2002). Minimal hippocampal width relates to plasma homocysteine in community-dwelling older people. Age and Ageing, 31, 440-444.